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Abstract
Diuretics use and overactive bladder syndrome are common in older adults. However, the relationship
between the two has not been well studied. Data were collected by self-administered questionnaires
including the Urge Urinary Distress Inventory (Urge-UDI) and the Urge Incontinence Impact
Questionnaire (Urge-IIQ), and by outpatient chart abstraction. Patients (n = 172) had a mean age of
79 ± 7.5 (± S.D.), 76% were women, and 48% were African Americans; 76% had hypertension, 32%
had heart failure, and 66% were receiving diuretics (57% loop diuretics). Overall, 72%, 68%, and
73% of patients respectively reported urinary frequency, urgency and urge incontinence. Diuretic
use was associated with increased frequency (81% versus 55% non-diuretic; odds ratio = OR = 3.48;
95% confidence interval = CI = 1.73–7.03) and urgency (74% versus 57% non-diuretic; OR = 2.17;
95% CI = 1.11–4.24) but not with incontinence (OR = 1.74; 95% CI = 0.87–3.50). When adjusted
for propensity scores, diuretic use had independent associations with frequency (adjusted OR = 3.09;
95% CI = 1.20–7.97) and urgency (adjusted OR = 2.50; 95% CI = 1.00–6.27). In addition to frequency
and urgency, loop diuretic use was also associated with incontinence (OR = 2.54; 95% CI = 1.09–
5.91), which lost significance after propensity adjustment (adjusted OR = 1.88; 95% CI = 0.57–6.17).
Overall summary mean Urge-IIQ score was 1.83 ± 0.85 (±S.D.) with 1.75 ± 0.86, 1.68 ± 0.76, and
2.03 ± 0.88, respectively for no-diuretic, non-loop, and loop-diuretic patients (one-way ANOVA p
= 0.063). Overactive bladder symptoms were common among ambulatory older adults and were
associated with diuretic use, and had stronger associations with loop diuretic use.
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1. Introduction
The overactive bladder syndrome, characterized by urinary urgency, frequency, nocturia and/
or urge incontinence, is common in older adults and may be negatively associated with quality
of life (Hampel et al., 1997; Brown et al., 1999; Lubeck et al., 1999; Brown, 2002; Abrams et
al., 2003; Odeyemi et al., 2006). Diuretic use is also common in older adults as the prevalence
of hypertension and heart failure increases with age (Donahue et al., 1990; Fried et al., 1998).
By causing diuresis or increased formation of urine by kidneys, diuretics increase urinary
frequency and may cause urinary urgency and incontinence. However, whether diuretic use is
associated with symptoms of overactive bladder and worsening quality of life has not been
well studied (Ouslander et al., 1987; Diokno et al., 1991; Fitzgerald et al., 2007). The objective
of this study was to evaluate the relationship between diuretic use and symptoms of overactive
bladder syndrome and to evaluate the impact of diuretics on overactive bladder symptoms’
related quality of life among ambulatory older adults.
2. Subjects and methods
2.1. Study design
This study is a cross-sectional survey of older adults attending an academic geriatric medicine
clinic between 2002 and 2005. Data on demographic variables, Urge-UDI and Urge-IIQ were
collected by self-administered questionnaires. The Urge-UDI was used to assess the presence
of overactive bladder symptoms and how much the symptoms bother the patients, while the
Urge-IIQ was used to evaluate the impact of overactive bladder on quality of life. These
measures have been validated in diverse populations of patients with urge urinary incontinence
and have been found to have excellent test-retest reliability. Scores range from 0–4 on the Urge-
UDI and 0–5 on the Urge-IIQ with higher scores indicating more severe bother and poorer
quality of life (Brown et al., 1999; Lubeck et al., 1999). Data on comorbidity, Mini Mental
State Examination (MMSE) score, Geriatric Depression Scale (GSE) score, and medications
were obtained by chart abstraction.
2.2. Study patients
Ambulatory older adults, 65 years and older, attending an academic, Geriatric Medicine
outpatient practice and who could read and respond to a written, English Language
questionnaire were eligible to participate. Trained study personnel approached patients for
participation in the study in the waiting room during routine clinic visits. The study protocol
was explained to patients by study coordinators and informed consents were obtained. Patients
who consented to participate were categorized into two groups based on use of diuretics, and
those receiving diuretics were further classified into taking loop and non-loop diuretics. A total
of 176 patients participated in the study. Four patients with incomplete data were excluded
from analysis. The protocol was approved by the Institutional Review Board.
2.3. Outcome variables
The primary outcomes were symptoms of overactive bladder including urinary urgency,
frequency, nocturia, and urge incontinence. Patients were asked to answer ‘yes’ or ‘no’ if they
experience any of these symptoms based on the Urge-UDI questionnaire. Secondary outcomes
were summary and domain-specific Urge-IIQ scores. The summary and domain-specific Urge-
IIQ scores were used to evaluate the overall impact of overactive bladder symptoms on quality
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of life and on the six domains of quality of life that may be affected by overactive bladder
(activities, travel, physical activities, feelings, relationships, and sexual function). The mean
Urge-UDI score was used to assess the severity of the symptoms of overactive bladder. Higher
scores on these measures indicate more severe bother and poorer quality of life.
2.4. Statistical analysis
We first compared baseline characteristics of patients receiving and not receiving diuretics
using Pearson’s chi-square and Student t-tests as appropriate. We then estimated propensity
scores for diuretic use for every patient by using a multivariable logistic regression model in
which diuretic use was the dependent variable (Ahmed et al., 2006, 2007a,b; Ahmed, 2007).
The propensity score for diuretic use for a patient is the conditional probability of receiving a
diuretic given that patient’s baseline characteristics (Rosenbaum and Rubin, 1983, 1984;
Rubin, 1997, 2001, 2004). Baseline patient characteristics included in the model were age,
gender, race, education, employment status, marital status, living status, diabetes, coronary
artery disease, heart failure, hypertension, urinary tract infection (UTI), use of angiotensin-
converting enzyme (ACE) inhibitors, beta blockers, angiotensin receptor blockers (ARB), and
serum creatinine. The propensity score, the composite single covariate representing all
measured baseline covariates used in the propensity score model, can be used to reduce
selection bias in observational studies.
The association between diuretic use and symptoms of overactive bladder was then assessed
using separate logistic regression models in which diuretic use was the predictor variable and
individual symptoms of overactive bladder were dependent variables. Each model was adjusted
for by raw propensity scores for diuretic use. We then repeated our analysis using traditional
multivariable logistic regression model that included key baseline covariates (age, gender, race,
education, employment status, marital status, living status, diabetes, coronary artery disease,
heart failure, hypertension, UTI, use of ACE-inhibitors, beta blockers, ARB and serum
creatinine). We also examined the association between the type of diuretic used and symptoms
of overactive bladder using loop and non-loop diuretics as dummy variables. One-way analysis
of variance test was used to estimate the differences between no diuretic, non-loop diuretic,
and loop diuretic use and the domain and overall mean scores of the Urge-IIQ and the Urge-
UDI. All tests were two-tailed, and a p-value of 0.05 or less was considered statistically
significant. All statistical analyses were conducted using the Statistical Package for the Social
Sciences (SPSS 14; SPSS Inc., Chicago, IL).
3. Results
3.1. Patient characteristics
Patients (n = 172) had a mean age of 79 ± 7.5 years, 76% were women, 48% were African
Americans, 76% had hypertension, 32% had heart failure, and 66% were receiving diuretics.
Overall, 72%, 68%, 73%, and 82% of patients respectively, reported urinary frequency,
urgency, urge incontinence, and nocturia, with an overall mean Urge-IIQ summary score of
1.83 ± 0.85. Baseline characteristics of patients by diuretic use are displayed in Table 1. Patients
on diuretics were more likely to be women and African Americans, and more likely to have
diabetes, coronary artery disease, heart failure, and hypertension.
3.2. Association of diuretic use with overactive bladder
Urinary frequency was reported by 55% of no-diuretic and 81% of diuretic patients (odds ratio
= OR = 3.48; 95% confidence interval = CI = 1.73–7.03; p < 0.0001). The association remained
significant after adjustment for propensity scores (adjusted OR = 3.09; 95% CI = 1.20–7.97;
p = 0.020; Table 2) and in the multivariable model (adjusted OR = 3.56; 95% CI = 1.29–9.82;
p = 0.014). Urinary urgency was reported by 57% of no-diuretic and 74% of diuretic patients
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(OR = 2.17; 95% CI = 1.11–4.24; p = 0.024). The association, however, lost its signi-ficance
after adjustment for propensity scores (adjusted OR = 2.50; 95% CI = 1.00–6.27; p = 0.051;
Table 2). Diuretic use was not associated with urinary incontinence or nocturia (Table 2).
3.3. No diuretic versus non-loop and loop diuretic use
Compared to patients not using diuretics, use of loop diuretic was associated with increased
urinary frequency (OR = 6.62; 95% CI = 2.58–16.94; p = <0.0001) and urgency (OR = 4.09;
95% CI = 1.75–9.59; p = 0.001). These associations remained significant after adjustment for
propensity scores (Table 3). Loop diuretic use was also associated with increased urge
incontinence (OR = 2.54; 95% CI = 1.09–5.91), but the association was no longer significant
after adjustment for propensity scores. Use of non-loop diuretic was not associated with
overactive bladder symptoms (Table 3).
3.4 Diuretic use and quality of life
The mean Urge-IIQ summary scores for patient not using diuretics, and those using non-loop
and loop diuretics were respectively 1.75 ± 0.86, 1.68 ± 0.76, and 2.03 ± 0.88, one-way
ANOVA p = 0.063 (Table 4). The mean Urge-IIQ domain-specific scores for patients’ not
using diuretics, and those using non-loop and loop diuretics are displayed in Table 4. Patient
characteristics and summary Urge-IIQ scores for patients from this study and two studies of
relatively younger patients with known overactive bladder syndrome (Brown, et al.,
1999;Lubeck, et al., 1999) are displayed in Table 5.
4. Discussion
4.1. Key findings
Findings from the current study demonstrate that symptoms of overactive bladder were
common among community-dwelling older adults attending a university-based geriatric clinic,
and that these symptoms had a strong negative impact on their quality of life. We also observed
that use of diuretics was associated with symptoms of overactive bladder, and these associations
were stronger with the use of more potent loop diuretics. To the best of our knowledge this is
the first report of an association of diuretic use with symptoms of overactive bladder and its
impact on quality of life of ambulatory older adults using Urge-UDI and Urge-IIQ and a
propensity score method. Loop diuretics are often needed for control of fluid volume in heart
failure, however they can activate neurohormones and cause electrolyte imbalance (Ahmed et
al., 2006; Ahmed et al., 2007c). Our findings demonstrate another, and often under-reported
adverse effect of these useful drugs among a population for which they are commonly
prescribed (Burgio et al., 1994).
4.2. Possible explanation of study findings
The high prevalence of overactive bladder symptoms in our study is likely due to aging and
use of diuretics. Data from laboratory animals and human overactive bladder suggest that age-
related functional, neuro-pharmacological, and morphological changes in the bladder may
predispose older adults to develop overactive bladder syndrome (Ordway et al., 1986; Inadome
et al., 1998; Yoshida et al., 2001, 2004). Diuretic-induced rapid production of urine may add
urgency to diuretic-associated frequency by triggering detrusor overactivity in the aging
bladder (Diokno et al., 1991; Steele et al., 1999). The lack of an association of diuretic use with
urinary incontinence in our study was likely due to the fact that a large number of these patients
were receiving non-loop diuretics for hypertension. This notion is supported by the fact that
use of more potent loop diuretics was associated with urge urinary incontinence. Despite a
reduction in the magnitude of the association and statistical significance after multivariable
adjustment, likely due to covariates such as age and comorbidities such as diabetes and heart
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failure, and the relatively small sample size, the association remained positive and strong.
Interestingly, in the subgroup receiving no diuretics, urge incontinence was more prevalent
than urinary frequency (Table 2). This may be due to age-related decrease in bladder sensation
resulting in incontinence without frequency (Griffiths et al., 2007). In contrast, in the group
receiving diuretics, urinary frequency was more prevalent than urinary incontinence, likely
due to increased urine volume from diuresis.
4.3. Comparison with other studies in the literature
Studies that evaluated symptoms of overactive bladder and diuretic use and its effect on quality
of life, particularly among non-institutionalized elderly population are scarce. Available
studies only assessed the symptoms of nocturia (Fitzgerald et al., 2007) and urinary
incontinence with diuretic use without consideration for symptoms of overactive bladder,
impact on quality of life, and the type of diuretics used (Ouslander et al., 1987; Diokno et al.,
1991). The impact of overactive bladder symptoms on quality of life in our study population
of community-dwelling older adults was high (Table 4 and Table 5) and comparable to those
reported by other investigators among younger patients with a diagnosis of overactive bladder
and urinary incontinence (Brown et al., 1999; Lubeck et al., 1999).
4.4. Clinical implications
Diuretics are commonly used in older adults as prevalence of chronic medical conditions such
as hypertension and heart failure, which require diuretic therapy is high in these patients.
Urinary frequency and urgency may lead to urge incontinence in those with delayed reaction
time to micturition sensation, particularly among older adults with impaired mobility.
Frequency and urgency may lead to rushing to the bathroom to avoid urge incontinent episodes,
thus increasing the risk of falls in older adults (Brown et al., 2000). Also, due to incontinence
or fear thereof, older adults may skip their medication if they need to go outside of the home,
which may affect compliance with diuretics. Although, taking loop diuretics at night might
interfere with sleep, taking them in mid afternoon can provide morning and early afternoon
time free of increased frequency and urgency.
Non-loop, thiazide-type diuretics are recommended by the current Joint National Committee
as the initial drug therapy for most patients with uncomplicated hypertension (Chobanian et
al., 2003). However, other antihypertensive drugs may be preferred initially when certain
comorbidities such as diabetes, chronic kidney disease, coronary artery disease and heart
failure, coexist (Chobanian, 2007). Because of high prevalence of these comorbidities in older
adults, use of non-diuretic anti-hypertensive drugs in these patients may reduce the symptoms
of overactive bladder and its negative impact on quality of life. Loop diuretics are essential to
control fluid volume in heart failure (Hunt et al., 2005). However, by using the lowest possible
dose needed to achieve and maintain euvolemia, it may be possible to minimize the untoward
effect of diuretics on overactive bladder.
4.5. Strengths and limitations
Cross sectional surveys are limited by recall bias. However, data on diuretic use and other
comorbidity were obtained from chart abstraction in this study. Lack of data on diuretic doses
and adherence is also a limitation of our study. Lastly, the cross-sectional design of the study
precludes any causal inference between diuretic use and overactive bladder symptoms.
5. Conclusions
The prevalence of symptoms of overactive bladder was high among ambulatory older adults
attending a university-based geriatric clinic and was associated with use of diuretics, especially
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with the use of loop diuretics. Clinicians should routinely ask their patients on diuretics about
symptoms of overactive bladder and offer treatment when feasible and appropriate.
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Table 1
Comparison of baseline characteristics of patients by diuretic use








  Age, year 78.8 ± 7.5 77.2 ± 7.6 79.6 ± 7.4 0.049
  Female 131(76.2) 39(66.1) 92(81.4) 0.037
  African American 83 (48.3) 18 (30.5) 65 (57.5) 0.001
  Education ≤high school 99 (57.6) 31(52.5) 68 (60.2) 0.336
  Not actively employed 160 (93.0) 51(86.4) 109 (96.5) 0.014
  Married 63 (36.6) 33 (55.9) 30 (26.5) <0.0001
  Living alone 69(40.1) 21 (35.6) 48 (42.5) 0.382
Co-morbid conditions
  Heart failure 55 (32.0) 5 (8.5) 50 (44.2) <0.0001
  Hypertension 130(75.6) 30 (50.8) 100(88.5) <0.0001
  Diabetes 57(33.1) 9(15.3) 48 (42.5) <0.0001
  Coronary artery disease 44 (25.6) 8(13.6) 36(31.9) 0.009
  UTI in the past 4 weeks 5 (2.9) 3(5.1) 2(1.8) 0.340
Medication use
  ACE inhibitors 84 (48.8) 15 (25.4) 69(61.1) <0.0001
  ARB 33 (19.2) 7(11.9) 26 (23.0) 0.078
  Beta-blockers 72 (41.9) 17 (28.8) 55 (48.7) 0.012
Others
  MMSE score 26.0 ± 4.3 26.6 ± 4.2 25.7 ± 4.4 0.313
  GDS score 3.7 ± 3.0 4.3 ± 3.6 3.5 ± 2.7 0.190
  Serum creatinine, mg/dl 1.20 ± 0.51 1.10 ± 0.27 1.25 ± 0.59 0.059
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Table 3
Unadjusted and adjusted odds ratio of association of overactive bladder symptoms







Reference OR (95% CI); p =< OR (95% CI); p =<
Frequency
  Unadjusted 1.00 1.92 (0.85–4.31); p = 0.117 6.62 (2.58–16.94); p < 0.0001
  Adjusted1 1.00 1.79 (0.65–4.93); p = 0.263 5.60 (1.61–19.45); p = 0.007
Urgency
  Unadjusted 1.00 1.17 (0.53–2.52); p = 0.714 4.09 (1.75–9.59); p = 0.001
  Adjusted1 1.00 1.30 (0.49–3.49); p = 0.601 6.10 (1.83–20.23); p = 0.003
Incontinence (urge)
  Unadjusted 1.00 1.16 (0.51–2.62); p = 0.725 2.54 (1.09–5.91); p = 0.031
  Adjusted1 1.00 1.04 (0.37–2.94); p = 0.940 1.88 (0.57–6.17); p = 0.301
Nocturia
  Unadjusted 1.00 0.93 (0.33–2.65); p = 0.897 0.75 (0.29–1.92); p = 0.550
  Adjusted1 1.00 1.28 (0.35–4.68); p = 0.711 1.45 (0.40–5.32); p = 0.574
1
Adjusted for propensity score
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Table 5
Comparison of Urge-IIQ and Urge-UDI among three studies
Brown et al. (1999) Lubeck et al. (1999) Our study
83 257 172
% or mean ± S.D.
Age, years 63.8 ± 11.6 59.6 ± 13.9 78.9 ± 7.5
Non-white 37 8 48
Female 100 91 76
Incontinence treatment 100 100 14.0
Urge-IIQ
Activities 2.8 ± 1.4 2.12 ± 1.14 2.11 ± 1.10
Travel 2.9 ± 1.6 2.26 ± 1.34 2.16 ± 1.15
Physical activities 2.7 ± 1.5 2.24 ± 1.33 1.49 ± 0.86
Feelings 2.4 ± 1.3 1.74 ± 1.33 1.65 ± 0.96
Relationships 1.7 ± 1.1 1.07 ± 1.22 1.53 ± 1.03
Sexual function 1.8 ± 1.4 1.28 ± 1.38 1.95 ± 1.36
Man summary score 2.40 ± 1.4 1.77 ± 1.68 1.83 ± 0.85
Urge-UDI
Urge symptoms 2.4 ± 1.0 2.37 ± 0.79 2.20 ± 0.90
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